1-3 of 3
Mayu Yunokawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C008: Phase I biomarker analysis of farletuzumab ecteribulin (FZEC), formerly MORAb-202, effects on cancer responses in patients with platinum resistant ovarian cancer

Free
Yan Zhang, Bob Zimmermann, Shuyu Li, Toshimitsu Uenaka, Keiji Furuuchi, Kan Yonemori, Toshio Shimizu, Shin Nishio, Mayu Yunokawa, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, Yasuyuki Hirashima, Hidenori Kato, Yohei Otake, Takuma Miura, Junji Matsui, Meijuan Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): C008.
https://doi.org/10.1158/1535-7163.TARG-23-C008
Published: 01 December 2023
View articletitled, Abstract C008: Phase I biomarker analysis of farletuzumab ecteribulin (FZEC), formerly MORAb-202, effects on cancer responses in patients with platinum resistant ovarian cancer
Journal Articles

Phase I and pharmacokinetic study of ABI-007, a Cremophor®-free nanoparticle formulation of paclitaxel, administered weekly in Japanese patients with solid tumors.

Free
Masashi Ando, Kan Yonemori, Eriko Nakanao, Mayu Yunokawa, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Noriyuki Katsumata, Yasuhiro Fujiwara, Mamoru Ooyane
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B74.
Published: 01 November 2007
View articletitled, Phase I and pharmacokinetic study of ABI-007, a Cremophor®-free nanoparticle formulation of paclitaxel, administered weekly in Japanese patients with solid tumors.
Journal Articles

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers

Free
Masaaki Komatsu, Keiko Hiyama, Keiji Tanimoto, Mayu Yunokawa, Keiko Otani, Megu Ohtaki, Eiso Hiyama, Junzo Kigawa, Michitaka Ohwada, Mitsuaki Suzuki, Nobutaka Nagai, Yoshiki Kudo, Masahiko Nishiyama
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 767–775.
https://doi.org/10.1158/1535-7163.MCT-05-0408
Published: 16 March 2006
View articletitled, Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers
Open the PDF for Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers in another window
Includes: Supplementary data